Stay Informed
Get insights delivered to your inbox
Subscribe to receive the latest research, perspectives, and strategic insights from Shapiro+Raj.
With a new administration stepping into power, the American healthcare community is caught between conflicting emotions—hope, anxiety, and an unshakable commitment to evidence-based medicine and patient care. While Americans in all sectors contemplate the impact of upcoming policy changes, for healthcare providers, this isn’t just political—it’s personal. Policy decisions shape their ability to deliver care, protect access, and uphold their mission to serve patients.
So, how are healthcare professionals responding? Shapiro+Raj set out to capture the voices that matter most. Our research with physicians across various specialties provides insight into how providers are reacting to and preparing for the new administration’s impact on healthcare.
These insights don’t just reflect the challenges ahead; they equip pharmaceutical companies and healthcare organizations with the strategic knowledge needed to align with provider priorities and deliver meaningful solutions in this transformative time.
A Community Divided
The research uncovers a pronounced split in provider perspectives that mirrors broader societal divisions. Only 30% of providers express optimism or enthusiasm about the incoming administration, while 44% report feelings of anxiety, sadness, or fear. 26% of providers occupy an ambivalent middle ground, reflecting widespread uncertainty about healthcare’s future direction.
This division becomes even more stark when viewed through the lens of political affiliation. Among liberal providers, 78% express deep pessimism about the incoming administration’s healthcare approach. Conservative providers present a markedly different outlook, with 33% maintaining strong optimism about the future.
These contrasting perspectives emerge vividly in providers’ own words. A medical oncologist represents the cautiously optimistic view:
Context
- Prior new indications had impressive efficacy data and first-to-market advantage, becoming the standard of care
- This new indication faced a more challenging, crowded environment requiring compelling positioning
- Needed to tap into established brand positioning while differentiating the new indication
- Time pressure: project overlapped with ongoing drivers/barriers and whitepaper testing
Looking Forward
This moment is as much about division as it is about resilience. Despite polarized perspectives, the healthcare community remains united in its dedication to patient care. For stakeholders—from pharma to payers—the challenge lies in embracing this complexity, addressing concerns on both sides, and aligning with providers’ shared purpose.
Success will require more than just understanding the data—it will demand empathy, agility, and innovative thinking to navigate this moment of profound uncertainty.
Stay tuned for the next installment in our series: Healthcare’s Perfect Storm: How Reimbursement Changes Could Reshape Medical Practices in 2025
Three Key Research Objectives
-
01
Discover an ownable and differentiated indication positioning informed by market value drivers, patient types, and clinical/non-clinical physician decision making
-
02
Determine the best way to articulate that positioning in order to raise the value of the brand point of difference in a way that makes physicians care
-
03
Ensure positioning fits with and amplifies the other indication's co-positioning and aligns with overall brand goals
This moment is as much about division as it is about resilience. Despite polarized perspectives, the healthcare community remains united in its dedication to patient care. For stakeholders—from pharma to payers—the challenge lies in embracing this complexity, addressing concerns on both sides, and aligning with providers’ shared purpose.
Success will require more than just understanding the data—it will demand empathy, agility, and innovative thinking to navigate this moment of profound uncertainty.
Stay tuned for the next installment in our series: Healthcare’s Perfect Storm: How Reimbursement Changes Could Reshape Medical Practices in 2025
Ready to differentiate your brand?
At Shapiro+Raj, we combine deep therapeutic knowledge with strategic positioning expertise to help pharmaceutical brands uncover ownable, differentiated market positions that drive launch success.
Contact us at communications@shapiroraj.com or visit our website www.shapiroraj.com to start a conversation about your positioning challenge.